Every year, we form a group of medical experts
Scientific Review Panels
A Scientific Review Panel exists for each type of grant we offer. The panels include a leader in the field of blood cancers and other medical experts responsible for the evaluation of grant applications. It consists of experienced researchers and clinicians who convene to discuss and rank applications based on rigorous criteria. Each member of the panel is carefully selected by the LLSC, in consultation with the appointed Chair who has varying expertise on blood cancer types and poses no conflict with the applicants. Once the applications are reviewed, the panel presents a recommendation for funding to the Medical & Scientific Advisory Committee.
Medical and Scientific Advisory Committee
The role of the Medical and Scientific Advisory Committee is to provide The Leukemia & Lymphoma Society of Canada insight on the state of blood cancer research, clinical care, and emerging trends and gaps, that are relevant to the blood cancer community. The committee is comprised of leading experts in their fields who volunteer their time to the LLSC and receive no compensation for their generous support.
Medical & Scientific Advisory Committee
Jennifer Marley, Chair, LLSC Board of Directors
Dr. Keith Humphries, Chair, LLSC Medical & Scientific Advisory Committee
Dr. Louis DeGennaro, President and CEO, LLS
Alicia Talarico, LLSC President
Nadine Prevost, LLSC Director, Community Engagement
Paul O'Connell, LLSC Manager, Medical & Scientific Engagement
Dr. Armand Keating, Princess Margaret Cancer Centre, University of Toronto
Dr. Trang Hoang, Institute for Research in Immunology and Cancer (IRIC)
Dr. Andrew Weng, BC Cancer Agency
Dr. Christian Steidl, BC Cancer Agency
Dr. Warren Pear, University of Pennsylvania
Dr. Aaron Schimmer, Princess Margaret Cancer Centre, University of Toronto